GlassScriptPhysician profile
Javed M Nasir
NPI 1295942381
$11,912.87
in general payments reported to CMS, 2019-2025
32 companies · $1,394 in 2025
The $1,394 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $844 · 2021: $2,601 · 2022: $808 · 2023: $4,242 · 2024: $1,745 · 2025: $1,394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,924 · Travel and Lodging: $1,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,923.50 |
| Travel and Lodging | $1,457.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,153.49 | 2019-2025 | Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit, Merlin@Home |
| Biosense Webster, INC. | $1,496.42 | 2020-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Biotronik INC. | $1,440.18 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Medtronic, INC. | $862.86 | 2021-2023 | Micra, Cobalt Dr Mri Surescan |
| Atricure, INC. | $493.16 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Impulse Dynamics (USA) INC. | $465.15 | 2023-2025 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $370.73 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $282.21 | 2020-2024 | Lifevest |
| Edwards Lifesciences Corporation | $266.98 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic Vascular, INC. | $255.73 | 2020 | |
| Esperion Therapeutics, INC. | $231.31 | 2021-2024 | Nexletol |
| Janssen Pharmaceuticals, INC | $219.58 | 2023-2024 | Xarelto |
| Boston Scientific Corporation | $152.03 | 2022-2025 | Farapulse, Bodyguardian, Varithena Administration Pack |
| Merck Sharp & Dohme LLC | $141.71 | 2023-2024 | Verquvo |
| Baxter Healthcare | $140.70 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $124.13 | 2021-2024 | Camzyos, Eliquis |
| Amgen INC. | $115.63 | 2023-2024 | Repatha |
| Philips North America LLC | $92.32 | 2024-2025 | (5044) Mcot, (5091) Amb Mon & Diag Und, Mcot |
| Shockwave Medical, INC | $85.80 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $84.24 | 2023-2025 | Wainua, Farxiga |
| Actelion Pharmaceuticals US, INC. | $80.66 | 2023-2024 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $75.43 | 2023-2024 | |
| Scpharmaceuticals INC. | $53.53 | 2023-2024 | |
| Ethicon US, LLC | $38.79 | 2024 | Surgicel Nu-Knit |
| Lexicon Pharmaceuticals, INC. | $38.66 | 2023-2024 | Inpefa |
| Reflow Medical INC | $29.87 | 2024 | |
| Kestra Medical Technology Services, INC. | $24.53 | 2024 | Assure Wcd |
| Angiodynamics, INC. | $24.10 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $23.35 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.82 | 2022 | |
| Alnylam Pharmaceuticals INC. | $17.59 | 2024 | Amvuttra |
| Abiomed | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javed Nasir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.